A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/20 (2006.01) A61K 31/202 (2006.01)
Patent
CA 2195979
A method of combating dyslexia, or inadequate night vision or dark adaptation in dyslexics or normal persons, and a method of manufacture of a medicament for such purposes, characterised by administering/incorporating DHA as an active in effective amount, optionally in association with other n-3 essential fatty acids and n-6 essential fatty acids.
Cette invention concerne un procédé de lutte contre la dyslexie ou contre l'insuffisance de la vision nocturne ou de l'adaptation à l'obscurité chez des personnes saines ou atteintes de dyslexie. Cette invention concerne également un procédé de fabrication d'un médicament adapté à ce type de traitement qui consiste à incorporer à ce médicament, qui sera ensuite administré à une personne, une quantité efficace d'acide docosahexanoïque (DHA) en tant que produit actif, éventuellement en association avec des acides gras essentiels n-3 et des acides gras essentiels n-6.
Scotia Holdings Plc
Sim & Mcburney
LandOfFree
Use of dha as a pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of dha as a pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dha as a pharmaceutical composition will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2022315